山东大学教师主页黄伯世 Paper Publications Home

7iw kp9 5aB qff gwz Zp1 tYl r8i l8G BDe TqG ZmK EUY EfT scJ 5kW mDV R4M pGM X2I

Huang Boshi

Doctor

Postgraduate (Postdoctoral)

山东大学

Recommended Ph.D.Supervisor

Recommended MA Supervisor

Personal Information

Gender:Male
Date of Employment:2022-10-14

Home > Scientific Research > Paper Publications

[1] . Discovery of novel fused-heterocycle-bearing diarypyrimidine derivatives as HIV-1 potent NNRTIs targeting tolerant region I for enhanced antiviral activity and resistance profile. EUROPEAN JOURNAL OF MEDICINAL CHEMIST..., 2024.
[2] 代娇娇. Discovery of novel fused-heterocycle-bearing diarypyrimidine derivatives as HIV-1 potent NNRTIs targeting tolerant region I for enhanced antiviral activity and resistance profile. EUROPEAN JOURNAL OF MEDICINAL CHEMIST..., 281, 2025.
[3] 黄伯世. Structure-Based Design and Discovery of Pyridyl-Bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling Studies. Journal of Medicianal Chemistry, 64, 13604-13621, 2021.
[4] 黄伯世. First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain. BIOORGANIC & MEDICINAL CHEMISTRY LETT..., 28, 1348, 2018.
[5] Design of bivalent ligands targeting putative GPCR dimers. Drug Discovery Today, 26, 189-199, 2021.
[6] Teaching an old dog new tricks: Drug discovery by repositioning natural products and their derivatives. Drug Discovery Today, 27, 1936-1944, 2022.
[7] Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mu.... Journal of Medicinal Chemistry, 62, 2083–2098, 2019.
[8] Structure-based Design and Discovery of Pyridyl-bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling Studies. Journal of Medicinal Chemistry, 64, 13604–13621, 2021.
[9] Structure-Based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity. Journal of Medicinal Chemistry, 64, 7702–7723, 2021.
[10] Rational Design, Chemical Syntheses, and Biological Evaluations of Peripherally Selective Mu Opioid Receptor Ligands as Potential Opioid Induced Constipation Treatment. Journal of Medicinal Chemistry, 65, 4991-5003, 2022.

TOTAL 10 PIECE 1/1

FIRSTPREVIOUSNEXTLAST

Home

Scientific Research

Teaching Research

Awards and Honours

Enrollment Information

Student Information

My Album

Blog

Recommended Ph.D.Supervisor

Recommended MA Supervisor

Personal Information